Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy
Objective To evaluate the impact of low-dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA-PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early-onset pre-eclampsia (PE).Methods This was a prospective observati...
| Autores: | , , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2025 |
| País: | España |
| Institución: | Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| Repositorio: | r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| OAI Identifier: | oai:iibsantpau.fundanetsuite.com:p20490 |
| Acceso en línea: | https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20490 |
| Access Level: | acceso abierto |
| Palabra clave: | first trimester low-dose aspirin placental biometry placental volume pre-eclampsia three-dimensional ultrasound two-dimensional ultrasound uterine artery Doppler |
| id |
ES_754c879faba931dfeb22cd751e655d58 |
|---|---|
| oai_identifier_str |
oai:iibsantpau.fundanetsuite.com:p20490 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancyTrilla, CPlatero, JMora, JNan, MNMedina, CAlejos, OParra, JLlurba, Efirst trimesterlow-dose aspirinplacental biometryplacental volumepre-eclampsiathree-dimensional ultrasoundtwo-dimensional ultrasounduterine artery DopplerObjective To evaluate the impact of low-dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA-PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early-onset pre-eclampsia (PE).Methods This was a prospective observational cohort study of 631 singleton pregnancies. Women at high risk of early-onset PE (delivery <= 33 + 6 weeks) were identified using maternal factors or a multivariate screening protocol and were prescribed LDA. Placental size was assessed using two- and three-dimensional ultrasonography, and UtA-PI was measured using transabdominal Doppler, with measurements obtained in the first and second trimesters. Differences in placental measurements and UtA-PI between high-risk women receiving LDA and low-risk untreated women were analyzed.Results Among the 631 participants, 53 (8.4%) women were prescribed LDA for the prevention of early-onset PE. Placental size in the first trimester was significantly smaller in the LDA group compared with the untreated group, as exemplified by placental volume (mean +/- SD, 68.46 +/- 25.19 cm3 vs 76.31 +/- 23.63 cm3; P = 0.022), and this trend persisted into the second trimester. However, no significant differences in placental growth from the first to the second trimester were observed between the groups. UtA-PI was significantly higher in the LDA group in both trimesters, but a greater decrease in UtA-PI multiples of the median values between trimesters was noted in these women (mean +/- SD, -14.0 +/- 0.28% vs -4.5 +/- 0.31%; P = 0.021). Perinatal outcomes were similar between the groups, with the exception of a higher rate of Cesarean delivery in the LDA group (38.5% vs 21.1%; P = 0.008).Conclusions Women at high risk for early-onset PE have a smaller placenta and higher UtA-PI in the first and second trimesters. Treatment of high-risk women with LDA did not affect placental growth but was associated with a greater reduction in UtA-PI, suggesting a positive effect of LDA on placental perfusion. These findings provide insight into the mechanism of action of LDA in the prevention of PE. (c) 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.WILEY2025info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20490ULTRASOUND IN OBSTETRICS & GYNECOLOGYISSN: 09607692ISSNe: 14690705reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauinstname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau)Inglésinfo:eu-repo/semantics/openAccessoai:iibsantpau.fundanetsuite.com:p204902026-06-14T12:41:47Z |
| dc.title.none.fl_str_mv |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| title |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| spellingShingle |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy Trilla, C first trimester low-dose aspirin placental biometry placental volume pre-eclampsia three-dimensional ultrasound two-dimensional ultrasound uterine artery Doppler |
| title_short |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| title_full |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| title_fullStr |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| title_full_unstemmed |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| title_sort |
Role of aspirin therapy in modulating uterine artery resistance and placental growth between first and second trimesters of pregnancy |
| dc.creator.none.fl_str_mv |
Trilla, C Platero, J Mora, J Nan, MN Medina, C Alejos, O Parra, J Llurba, E |
| author |
Trilla, C |
| author_facet |
Trilla, C Platero, J Mora, J Nan, MN Medina, C Alejos, O Parra, J Llurba, E |
| author_role |
author |
| author2 |
Platero, J Mora, J Nan, MN Medina, C Alejos, O Parra, J Llurba, E |
| author2_role |
author author author author author author author |
| dc.subject.none.fl_str_mv |
first trimester low-dose aspirin placental biometry placental volume pre-eclampsia three-dimensional ultrasound two-dimensional ultrasound uterine artery Doppler |
| topic |
first trimester low-dose aspirin placental biometry placental volume pre-eclampsia three-dimensional ultrasound two-dimensional ultrasound uterine artery Doppler |
| description |
Objective To evaluate the impact of low-dose aspirin (LDA) on placental size and uterine artery pulsatility index (UtA-PI) by analyzing longitudinal changes between the first and second trimesters in pregnancies at high risk for early-onset pre-eclampsia (PE).Methods This was a prospective observational cohort study of 631 singleton pregnancies. Women at high risk of early-onset PE (delivery <= 33 + 6 weeks) were identified using maternal factors or a multivariate screening protocol and were prescribed LDA. Placental size was assessed using two- and three-dimensional ultrasonography, and UtA-PI was measured using transabdominal Doppler, with measurements obtained in the first and second trimesters. Differences in placental measurements and UtA-PI between high-risk women receiving LDA and low-risk untreated women were analyzed.Results Among the 631 participants, 53 (8.4%) women were prescribed LDA for the prevention of early-onset PE. Placental size in the first trimester was significantly smaller in the LDA group compared with the untreated group, as exemplified by placental volume (mean +/- SD, 68.46 +/- 25.19 cm3 vs 76.31 +/- 23.63 cm3; P = 0.022), and this trend persisted into the second trimester. However, no significant differences in placental growth from the first to the second trimester were observed between the groups. UtA-PI was significantly higher in the LDA group in both trimesters, but a greater decrease in UtA-PI multiples of the median values between trimesters was noted in these women (mean +/- SD, -14.0 +/- 0.28% vs -4.5 +/- 0.31%; P = 0.021). Perinatal outcomes were similar between the groups, with the exception of a higher rate of Cesarean delivery in the LDA group (38.5% vs 21.1%; P = 0.008).Conclusions Women at high risk for early-onset PE have a smaller placenta and higher UtA-PI in the first and second trimesters. Treatment of high-risk women with LDA did not affect placental growth but was associated with a greater reduction in UtA-PI, suggesting a positive effect of LDA on placental perfusion. These findings provide insight into the mechanism of action of LDA in the prevention of PE. (c) 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology. |
| publishDate |
2025 |
| dc.date.none.fl_str_mv |
2025 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20490 |
| url |
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=20490 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
WILEY |
| publisher.none.fl_str_mv |
WILEY |
| dc.source.none.fl_str_mv |
ULTRASOUND IN OBSTETRICS & GYNECOLOGY ISSN: 09607692 ISSNe: 14690705 reponame:r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname:Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| instname_str |
Institut d’Investigació Biomèdica Sant Pau (IIB Sant Pau) |
| reponame_str |
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| collection |
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869410970478051328 |
| score |
15.811543 |